Nonpharmacologic pain intervention provides benefits to people with dialysis-dependent kidney failure

PD-1 inhibition before and after surgery for high-risk early triple-negative breast cancer (TNBC) led to significant improvement in overall survival (OS), according to updated results

Am­gen has sealed its high-pro­file $27.8 bil­lion pur­suit of Hori­zon Ther­a­peu­tics, clos­ing the deal af­ter a lengthy 10-month ac­qui­si­tion process in which the Fed­er­al Trade